Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Return on Equity [ROE] (2017 - 2026)

Updated

Avenue Therapeutics' Return on Equity [ROE] came in at -317.26% for Q2 2026, down 78.11 percentage points from -239.16% a year earlier and down 199.51 percentage points from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Return on Equity [ROE] (2017 - 2026) Analysis & Trends

For FY2025, Avenue Therapeutics' Return on Equity [ROE] was -159.82%, up 772.14 percentage points from FY2024.

  • Return on Equity [ROE] carries a five-year change of -47.34 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -931.95% in FY2024 (-396.85 pp), -535.10% in FY2023 (-427.82 pp), -107.28% in FY2022 (+21.15 pp) and -128.43% in FY2021 (-15.95 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q1 2025.
  • Year-over-year, Return on Equity [ROE] increased in four of the last six quarters, with an average year-over-year change of +187.57 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2024 (a gain of 937.77 percentage points), and the weakest in Q3 2021 (a drop of 1320.31 percentage points).
  • Business Quant data shows ATXI's Return on Equity [ROE] at -117.76% (Q1 2026), -109.37% (Q4 2025) and -118.33% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 19.33%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.21%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 21.39%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -18.38%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 4.97%
10 Avenue Therapeutics 1.27 Mn -9.65 Mn - -317.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -317.26%
Mar 31, 2026 -117.76%
Dec 31, 2025 -109.37%
Sep 30, 2025 -118.33%
Jun 30, 2025 -239.16%
Mar 31, 2025 -439.59%
Dec 31, 2024 -666.82%
Sep 30, 2024 -347.51%
Jun 30, 2024 -206.81%
Mar 31, 2024 -567.01%
Mar 31, 2023 -1,504.78%
Dec 31, 2022 -223.30%
Sep 30, 2022 -1,803.22%
Jun 30, 2022 -597.50%
Mar 31, 2022 -242.69%
Dec 31, 2021 -226.74%
Sep 30, 2021 -1,581.33%
Jun 30, 2021 -374.87%
Mar 31, 2021 -255.97%
Dec 31, 2020 -184.19%
API Access

Avenue Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATXI&period=max&api_key=YOUR_API_KEY